XML 66 R49.htm IDEA: XBRL DOCUMENT
v3.25.3

Business Segment Information (Tables) | 12 Months Ended
--- | ---
Jul. 31, 2025
Business Segment Information [Abstract] |
Schedule of Operating Results for the Business Segments | Operating results for the business segments of the Company are as follows:
(in thousands) |  | Healthcare |  |  | Infusion Technology |  |  | Real Estate |  |  | Total |
Year Ended July 31, 2025 |  |  |  |  |  |  |  |  |  |  |  |
Infusion technology revenue |  | $ | — |  |  | $ | 93 |  |  | $ | — |  |  | $ | 93 |
Rental – Third Party |  |  | — |  |  |  | — |  |  |  | 197 |  |  |  | 197 |
Rental – Related Party |  |  | — |  |  |  | — |  |  |  | 112 |  |  |  | 112 |
Product revenue |  |  | 515 |  |  |  | — |  |  |  | — |  |  |  | 515 |
COSTS AND EXPENSES |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cost of Infusion Technology revenue |  |  | — |  |  |  | (106 | ) |  |  | — |  |  |  | (106 | )
Cost of product revenue |  |  | (28 | ) |  |  | — |  |  |  | — |  |  |  | (28 | )
General and administrative |  |  | (13,165 | ) |  |  | (320 | ) |  |  | (296 | ) |  |  | (13,781 | )
Research and development |  |  | (12,568 | ) |  |  | (255 | ) |  |  | — |  |  |  | (12,823 | )
Depreciation and amortization |  |  | (48 | ) |  |  | (177 | ) |  |  | (63 | ) |  |  | (288 | )
Loss on impairment of goodwill |  |  | — |  |  |  | (3,050 | ) |  |  | — |  |  |  | (3,050 | )
Loss from operations |  | $ | (25,294 | ) |  | $ | (3,815 | ) |  | $ | (50 | ) |  | $ | (29,159 | )
(in thousands) |  | Healthcare |  |  | Infusion Technology |  |  | Real Estate |  |  | Total |
Year Ended July 31, 2024 |  |  |  |  |  |  |  |  |  |  |  |
Infusion technology revenue |  | $ | — |  |  | $ | 355 |  |  | $ | — |  |  | $ | 355 |
Rental – Third Party |  |  | — |  |  |  | — |  |  |  | 174 |  |  |  | 174 |
Rental – Related Party |  |  | — |  |  |  | — |  |  |  | 108 |  |  |  | 108 |
COSTS AND EXPENSES |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cost of Infusion Technology revenue |  |  | — |  |  |  | (154 | ) |  |  | — |  |  |  | (154 | )
General and administrative |  |  | (8,338 | ) |  |  | (374 | ) |  |  | (142 | ) |  |  | (8,854 | )
Research and development |  |  | (3,668 | ) |  |  | (502 | ) |  |  | — |  |  |  | (4,170 | )
In-process research and development |  |  | (89,861 | ) |  |  | — |  |  |  | — |  |  |  | (89,861 | )
Depreciation and amortization |  |  | (165 | ) |  |  | — |  |  |  | (60 | ) |  |  | (225 | )
(Loss) income from operations |  | $ | (102,032 | ) |  | $ | (675 | ) |  | $ | 80 |  |  | $ | (102,627 | )
A reconciliation between loss from operations by reportable segment to consolidated net loss before income taxes for the years ended July 31, 2025 and 2024, is as follows:
(in thousands) |  | July 31, 2025 |  |  | July 31, 2024 |
(Loss) income from operations by segment |  |  |  |  |  |
Healthcare |  | $ | (25,294 | ) |  | $ | (102,032 | )
Infusion Technology |  |  | (3,815 | ) |  |  | (675 | )
Real Estate |  |  | (50 | ) |  |  | 80 |
Total |  |  | (29,159 | ) |  |  | (102,627 | )
Reconciliation to loss before income taxes: |  |  |  |  |  |  |  |
Interest income |  |  | 1,996 |  |  |  | 2,383 |
Loss on initial investment in Day Three upon acquisition |  |  | — |  |  |  | (1,633 | )
Realized gain on available-for-sale securities |  |  | 178 |  |  |  | 1,772 |
Realized loss on investment in equity securities |  |  | — |  |  |  | (46 | )
Realized gain on investment - Cyclo |  |  | — |  |  |  | 424 |
Unrealized (loss) gain on investment - Cyclo |  |  | (5,144 | ) |  |  | 37 |
Unrealized (loss) gain on convertible notes receivable, due from Cyclo |  |  | (719 | ) |  |  | 1,191 |
Unrealized gain on investment - Hedge Funds |  |  | — |  |  |  | 63 |
Recovery of receivables from Cornerstone |  |  | — |  |  |  | 31,305 |
Interest expense |  |  | (658 | ) |  |  | (248 | )
Other income, net |  |  | 310 |  |  |  | 118 |
Loss before income taxes |  | $ | (33,196 | ) |  | $ | (67,261 | )
Schedule of Net Property, Plant and Equipment | Net property, plant, and equipment and total assets summarized by geographic area are as follows:
(in thousands) |  | United States |  |  | Israel |  |  | Total |
July 31, 2025 |  |  |  |  |  |  |  |  |
Property, plant and equipment, net |  | $ | 321 |  |  | $ | 1,275 |  |  | $ | 1,596 |
Total assets |  |  | 111,954 |  |  |  | 2,155 |  |  |  | 114,109 |
July 31, 2024 |  |  |  |  |  |  |  |  |  |  |  |
Property, plant and equipment, net |  | $ | 783 |  |  | $ | 1,337 |  |  | $ | 2,120 |
Total assets |  |  | 93,434 |  |  |  | 3,398 |  |  |  | 96,832 |

X
- Definition Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration